BWL
STRO icon

Bogart Wealth LLC’s Sutro Biopharma STRO Stock Holding History

Bogart Wealth LLC’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66K Hold
50
– – ﹤0.01% 1508
2026
Q1 		$1.25K Hold
50
– – ﹤0.01% 1392
2025
Q4 		$579 Hold
50
– – ﹤0.01% 1420
2025
Q3 		$434 Hold
50
– – ﹤0.01% 1454
2025
Q2 		$357 Hold
50
– – ﹤0.01% 1383
2025
Q1 		$325 Hold
50
– – ﹤0.01% 1329
2024
Q4 		$920 Hold
50
– – ﹤0.01% 1215
2024
Q3 		$1.73K Hold
50
– – ﹤0.01% 983
2024
Q2 		$1.47K Hold
50
– – ﹤0.01% 974
2024
Q1 		$2.83K Hold
50
– – ﹤0.01% 864
2023
Q4 		$2.15K Hold
50
– – ﹤0.01% 889
2023
Q3 		$1.74K Hold
50
– – ﹤0.01% 901
2023
Q2 		$2.33K Hold
50
– – ﹤0.01% 862
2023
Q1 		$2.31K Buy
+50
New +$3.17K ﹤0.01% 885

Other funds holding STRO

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
OCWP
Owl Creek Wealth Partners Denver, Colorado $342M AUM
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Bogart Wealth LLC's STRO Position: Q2 2026 in Review

Bogart Wealth LLC held its Sutro Biopharma (STRO) position steady in Q2 2026 at 50 shares worth $1.66K. The position accounts for ﹤0.01% of the portfolio, ranked #1508.

Bogart Wealth LLC first reported a position in STRO in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.83K in Q1 2024. 8 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Bogart Wealth LLC held 50 shares of Sutro Biopharma worth $1.66K as of Q2 2026.
  • Bogart Wealth LLC left its Sutro Biopharma share count unchanged in Q2 2026.
  • Sutro Biopharma made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1508 holding.
  • Bogart Wealth LLC first reported a position in Sutro Biopharma in Q1 2023 and has held it in 14 quarters since.
  • Bogart Wealth LLC's Sutro Biopharma position peaked at $2.83K in Q1 2024.
  • 8 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.